Skip to main content
TU $9.76 +0.83%
TU logo

TU · Telus Corp

Track TU — free
$9.76 +0.08 (+0.83%) At close · Aug 14
Market Cap
$14.99B
Shares
1.57B
All earnings calls

Earnings call · FY2025 Q2

Telus Corp Q2 FY2025 Earnings Call

Telus Corp Q2 FY2025 Earnings Call

Concluded Jun 30, 2025
Jun 30, 2025 53 turns
Period
FY2025 Q2
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Tower infrastructure monetization (Terrion) 15 TELUS Health growth and synergies 14 Financial outlook and free cash flow 9 PureFibre and broadband expansion 9 Industry pricing and competitive dynamics 6 AI and operational efficiency 5

Management tone

Confident

Net tone +65 · low hedging

Grounding quotes
  • “These results demonstrate the strength of our leading portfolio of bundled offerings across mobile and home and the strategic expansion of TELUS PureFibre connectivity to homes and businesses, inclusive of Ontario and Quebec.”
  • “We achieved total mobile and fixed customer growth of 198,000 in the quarter. This was driven by mobile phone and connected device additions of 167,000 alongside fixed customer additions of 31,000.”
  • “Looking ahead, our financial position and our operational outlook remains strong, supported by continued EBITDA growth and stable capital expenditures, resulting in a meaningful free cash flow expansion on a chronic basis prospectively.”
  • “Since acquiring LifeWorks, we've realized $400 million in combined annualized synergies. You may recollect that our original target in this regard was $150 million to $200 million.”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

1 live source

Switch sources without leaving this page or losing your listening position.

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
TTech, including Health, operating revenues growth
2025
2% – 4%
TTech, including Health, adjusted EBITDA growth
2025
3% – 5%
Consolidated free cash flow
2025
$2.15B
Consolidated capital expenditures, excluding real estate of $100
2025
$2.5B
Full-screen source Call document